Biotechnology: Biological Products (No Diagnostic Substances)

Business UpdateJul 29, 2026, 08:09 AM

Candel Therapeutics to Present at Canaccord Genuity Conference

AI Summary

Candel Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced it will present at Canaccord Genuity's 46th Annual Growth Conference. The presentation is scheduled for August 12, 2026, at 12 PM EDT. A webcast of the presentation will be accessible via the company's investor relations website, with a replay available for 90 days. The company focuses on developing multimodal immunotherapies for cancer.

Key Highlights

Candel Therapeutics will present at Canaccord Genuity's 46th Annual Growth Conference.
The presentation is scheduled for Wednesday, August 12, 2026.
The presentation will take place at 12 PM EDT.
A webcast of the presentation will be available on Candel's investor relations website.
A replay of the webcast will be archived for up to 90 days.

View SEC Filing

CADL

Biotechnology: Biological Products (No Diagnostic Substances)

Candel Therapeutics, Inc.

Price Impact